Loading...
ROCO
4127
Market cap105mUSD
Jul 09, Last price  
74.00TWD
1D
-6.92%
1Q
103.86%
Jan 2017
316.90%
IPO
360.77%
Name

Tien Liang Biotech Co Ltd

Chart & Performance

D1W1MN
ROCO:4127 chart
P/E
P/S
6.62
EPS
Div Yield, %
0.68%
Shrs. gr., 5y
Rev. gr., 5y
3.49%
Revenues
512m
+32.86%
435,860,000431,083,000571,316,000528,523,000459,993,000385,206,000511,793,000
Net income
-10m
L
-46,776,000-51,637,00046,605,00059,481,00017,732,00011,696,000-10,251,000
CFO
38m
-22.38%
-41,708,000-10,822,00045,206,00021,880,00069,670,00048,342,00037,525,000
Dividend
Aug 27, 20240.5 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New Taipei City, Taiwan, is a pharmaceutical enterprise involved in the development, manufacturing, and global distribution of a diverse array of health and medicinal products. The company's offerings include traditional Chinese medicine (TCM) formulations, predominantly in pill form. These remedies address a broad spectrum of conditions, such as internal organ deficiencies (e.g., liver and kidney), various forms of musculoskeletal and neuropathic discomfort (including low back pain, joint pain, rheumatism, gout, and neuralgia), and common ailments like dizziness, digestive issues (constipation, hemorrhoids), respiratory symptoms (colds, bronchitis, coughs), and skin conditions (athlete's foot). Additionally, Tien Liang BioTech provides a range of Western pharmaceutical products. This segment features topical applications like ointments, pain relief gels, soreness sprays, and transdermal pain patches, alongside oral preparations such as tablets and capsules. The portfolio also includes specialized items like hair removal creams. Beyond pharmaceuticals, the company extends its reach into general consumer health and personal care. These offerings comprise products designed for body relaxation and comfort, items to alleviate post-exercise discomfort, oral hygiene products, and various soaps.
IPO date
Jan 14, 2003
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT